Advanced Life Sciences Holdings, Inc.Company Review & Valuation

ADLS
OTC Markets

About Advanced Life Sciences Holdings, Inc.

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs in the therapeutic areas of infection, oncology, and respiratory disease. The company's lead product candidate includes Restanza, a once-a-day oral antibiotic forShow more the treatment of respiratory tract infections, including community acquired bacterial pneumonia and biodefense pathogens, such as anthrax, plague, and tularemia. It is also developing ALS-357, a compound for the topical treatment of malignant melanoma; and ALS-886, a therapeutic for the treatment of inflammation-related tissue damage consisting of tissue damage associated with acute respiratory distress syndrome. The company has collaboration agreements with Abbott Laboratories to develop and commercialize cethromycin; University of Illinois to develop, make, use, and sell ALS-357 and related compounds; and Baxter International, Inc. Advanced Life Sciences Holdings, Inc. was founded in 1999 and is headquartered in Woodridge, Illinois. Show less

Industry
Biotechnology
HQ Location
Woodridge, Illinois

Stock Price

Price data not available for Advanced Life Sciences Holdings, Inc..

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top